Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumors × Metoclopramide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Vomiting 5 Nausea 4 Neoplasms 3 Lymphoma 2 Solid Tumors 1 Prostatic Neoplasms 1 Polyps 1 Mouth Neoplasms 1 Metastatic Neuroendocrine Prostate Cancer 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Intestinal Obstruction 1 Hypopharyngeal Neoplasms 1 Critical Illness 1 Colonic Neoplasms 1 Breast Neoplasms 1

Interventions

Paclitaxel 12 Gemcitabine 10 pembrolizumab 8 atezolizumab 8 Carboplatin 8 Irinotecan 7 Docetaxel 7 Bevacizumab 7 Sunitinib 5 Leucovorin 5 Injections 5 Fluorouracil 5 Cyclophosphamide 5 Cetuximab 5 Capecitabine 5 olaparib 4 navitoclax 4 Topotecan 4 Oxaliplatin 4 Nivolumab 4 Erlotinib Hydrochloride 4 spartalizumab 3 liposomal doxorubicin 3 lenvatinib 3 fludarabine 3 Cisplatin 3 zolbetuximab 2 tocilizumab 2 tivozanib 2 tislelizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02135510 2020-03-31

MEDEA

Amsterdam UMC, location VUmc

Phase 3 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡